Literature DB >> 25797967

ROLES OF PUBLIC HEALTH CENTERS (HOKENJO) IN TUBERCULOSIS CONTROL IN JAPAN.

Nobuyuki Katsuda1, Tomoya Hirosawa2, Joshua A Reyer2, Nobuyuki Hamajima2.   

Abstract

Public health centers (PHCs, hokenjo in Japanese) are local government authorities responsible for public health in Japan. PHCs have an important role in tuberculosis (TB) control. Typically, their responsibilities include 1) the recommendation to admit infectious TB patients to an isolation ward, 2) health checkups with chest X-ray of those in a close contact with infectious TB patients, and 3) public subsidy of medical expenses for TB treatments. Facing the emergence of multi-drug resistant tuberculosis (MDR-TB), the national TB control program was drastically changed; the Japanese version of the Directly Observed Treatment in Short-course (DOTS) strategy was started in 2005. New roles were added to PHCs' responsibilities; 1) active screening of latent TB infection by interferon gamma release assays for those in a close contact with infectious TB patients, 2) community DOTS to promote treatment adherence to outpatients, 3) cohort analysis of outcomes of TB treatment, and 4) national MDR-TB surveillance. These roles are important in preventing MDR-TB and eliminating TB in Japan.

Entities:  

Keywords:  DOTS strategy; Infectious Disease Act.; latent tuberculosis infection; multi-drug resistant tuberculosis; public health center

Year:  2015        PMID: 25797967      PMCID: PMC4361504     

Source DB:  PubMed          Journal:  Nagoya J Med Sci        ISSN: 0027-7622            Impact factor:   1.131


  23 in total

1.  Drug resistance among failure and relapse cases of tuberculosis: is the standard re-treatment regimen adequate?

Authors:  H T W Quy; N T N Lan; M W Borgdorff; J Grosset; P D Linh; L B Tung; D van Soolingen; M Raviglione; N V Cô; J Broekmans
Journal:  Int J Tuberc Lung Dis       Date:  2003-07       Impact factor: 2.373

2.  [Treatment of acid-fast bacterial infection based on the PK/PD theory].

Authors:  Kazuhiko Hanada
Journal:  Kekkaku       Date:  2010-12

3.  Resistance of Mycobacterium tuberculosis to four first-line anti-tuberculosis drugs in Japan, 1997.

Authors:  C Abe; K Hirano; M Wada; T Aoyagi
Journal:  Int J Tuberc Lung Dis       Date:  2001-01       Impact factor: 2.373

4.  Factors associated with declining numbers of chronic tuberculosis excretors in Japan.

Authors:  H Hoshino; K Uchimura; S Kato
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

5.  Current epidemiological trend of tuberculosis in Japan.

Authors:  M Ohmori; N Ishikawa; T Yoshiyama; K Uchimura; M Aoki; T Mori
Journal:  Int J Tuberc Lung Dis       Date:  2002-05       Impact factor: 2.373

6.  [Evaluation of effect of community DOTS on treatment outcomes by TB surveillance data].

Authors:  Hitoshi Hoshino; Noriko Kobayashi
Journal:  Kekkaku       Date:  2006-10

7.  Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan.

Authors:  Jung-Yien Chien; Chih-Cheng Lai; Che-Kim Tan; Shun-Tien Chien; Chong-Jen Yu; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2013-04-10       Impact factor: 5.790

8.  [Tuberculosis control in Kawasaki City--promoting the DOT program].

Authors:  Yuki Tada; Masako Ohmori; Kunihiko Ito; Michiko Fujiu
Journal:  Kekkaku       Date:  2004-01

9.  Outcome of directly observed therapy for tuberculosis in Yokohama City, Japan.

Authors:  K Tsuchida; H Koyanagi
Journal:  Int J Tuberc Lung Dis       Date:  2003-08       Impact factor: 2.373

10.  [Evaluation of the effect of DOTS on treatment outcomes in patients with smear-positive pulmonary tuberculosis in Osaka City].

Authors:  Kenji Matsumoto; Jun Komukai; Hideki Yoshida; Satoshi Hirota; Shinichi Koda; Kazuhiko Terakawa; Akira Shimouchi
Journal:  Kekkaku       Date:  2012-11
View more
  10 in total

1.  Tuberculosis-related technical enquiries received by a national level institution in Japan, 2014-2016.

Authors:  M Urakawa; A Yasukawa; Y Hoshino; T Shimamura; S Hirao; Y Nagata; M Ota
Journal:  Public Health Action       Date:  2018-09-21

Review 2.  Medical facility statistics in Japan.

Authors:  Nobuyuki Hamajima; Takuya Sugimoto; Ryo Hasebe; Su Myat Cho; Moe Khaing; Tetsuyoshi Kariya; Yu Mon Saw; Eiko Yamamoto
Journal:  Nagoya J Med Sci       Date:  2017-11       Impact factor: 1.131

3.  Risk of tuberculosis among air passengers estimated by interferon gamma release assay: survey of contact investigations, Japan, 2012 to 2015.

Authors:  Masaki Ota; Seiya Kato
Journal:  Euro Surveill       Date:  2017-03-23

4.  Efficacy and safety of concurrent anti-Cancer and anti-tuberculosis chemotherapy in Cancer patients with active Mycobacterium tuberculosis: a retrospective study.

Authors:  Tomonori Hirashima; Yoshitaka Tamura; Yuki Han; Shoji Hashimoto; Ayako Tanaka; Takayuki Shiroyama; Naoko Morishita; Hidekazu Suzuki; Norio Okamoto; Shinobu Akada; Makoto Fujishima; Yoshihisa Kadota; Kazuya Sakata; Akiko Nishitani; Satoru Miyazaki; Takayuki Nagai
Journal:  BMC Cancer       Date:  2018-10-12       Impact factor: 4.430

5.  A tuberculosis outbreak at an insecure, temporary housing facility, manga café, Tokyo, Japan, 2016-2017.

Authors:  M Endo; M Ota; A Kayebeta; I Takahashi; Y Nagata
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  A tuberculosis outbreak in a psychiatric hospital: Kanagawa, Japan, 2012.

Authors:  M Tasaka; E Koeda; C Takahashi; M Ota
Journal:  Epidemiol Infect       Date:  2020-01-14       Impact factor: 2.451

7.  Tuberculosis Surveillance and Monitoring under the National Public-Private Mix Tuberculosis Control Project in South Korea 2016-2017.

Authors:  Jinsoo Min; Hyung Woo Kim; Yousang Ko; Jee Youn Oh; Ji Young Kang; Joosun Lee; Young Joon Park; Sung-Soon Lee; Jae Seuk Park; Ju Sang Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2020-06-18

8.  A tuberculosis contact investigation involving a large number of contacts tested with interferon-gamma release assay at a nursing school: Kanagawa, Japan, 2012.

Authors:  Masako Tasaka; Tamae Shimamura; Mami Iwata; Takahiro Toyozawa; Masaki Ota
Journal:  Western Pac Surveill Response J       Date:  2018-08-06

9.  Patient support for tuberculosis patients in low-incidence countries: A systematic review.

Authors:  Sarah van de Berg; Niesje Jansen-Aaldring; Gerard de Vries; Susan van den Hof
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

10.  Impact of Routine Infant BCG Vaccination on COVID-19.

Authors:  Masako Kinoshita; Masami Tanaka
Journal:  J Infect       Date:  2020-08-12       Impact factor: 6.072

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.